Device Biosurgical

Surgiflo Hemostatic Matrix

Payments companies reported to CMS as associated with Surgiflo Hemostatic Matrix. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$904Kassociated payments (2023-2025)
2,916clinicians with associated payments
6companies reporting

By year

2023 $202K
2024 $318K
2025 $385K

Payments reported as associated with Surgiflo Hemostatic Matrix, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $246K
Neurological Surgery $128K
Surgery $114K
Orthopaedic Surgery of The Spine $104K
Surgical Critical Care $39K
Gynecologic Oncology $39K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Surgiflo Hemostatic Matrix

These are the largest totals companies reported as associated with Surgiflo Hemostatic Matrix. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Faraz Kerendi Austin, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $132,332.87
Grayson Wheatley Nashville, TN Thoracic Surgery (Cardiothoracic Vascular Surgery) $99,357.33
Lindsey Ross Los Angeles, CA Neurological Surgery $59,086.87
Eric Klineberg Sacramento, CA Orthopaedic Surgery of The Spine $53,942.32
Richard Nguyen Los Gatos, CA Surgery $53,320.80
Andrew Nunn Winston Salem, NC Surgical Critical Care $37,975.76
Gitonga Munene Kalamazoo, MI Surgical Oncology $34,572.90
Adnan Alseidi Seattle, WA Surgery $29,172.00
Jonathan Black Miramar, FL Gynecologic Oncology $28,190.97
Sean Jones Quaidoo Dallas, TX Orthopaedic Surgery of The Spine $24,991.33

Prescribed Surgiflo Hemostatic Matrix?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.